The Yorkshire technology firm has raised seed funding from Angelfish to accelerate product development and international expansion.
"Angelfish is delighted to increase its holding in yboo and to be negotiating the potential injection of substantial funds to secure the rollout and expansion of the yboo model. In the last few months, since the initial funding, yboo has significantly advanced the technology behind the model and attract considerable trade interest within the price comparison sector."
The investment round was led by Committed Capital and Mercia Fund Managers to support product team expansion.
"The world around us is getting busier and more complicated every day. Our map-based applications, which provide access to timely, relevant location-based information about any environment, are the key to enabling consumers and businesses to find their way."
The funding round was led by Cambridge Enterprise with participation from Amadeus Capital Partners, Parkwalk Advisors, IQ Capital Partners and angel investors.
"The new Paragraf facility is a significant step towards realising the potential of graphene in commercially viable, scalable electronic devices, bringing the beneficial impacts of this wonder material to the world."
The seed round was led by Mercia Fund Management with backing from angel investors.
"Mercia is the perfect partner for us, as their 'Complete Capital Solution' will be able to meet our needs as a personalised healthcare technology start-up. We need an investor that understands our journey ahead and can help us plan for future growth."
